ArticlePharmacoEconomics - open2026

Economic Impact of PromarkerD In Vitro Diagnostic Testing on the Management of Chronic Kidney Disease in Type 2 Diabetes: A Budget Impact Analysis.

Gareth C Fernandez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.